{
    "Trade/Device Name(s)": [
        "IMMULITE/IMMULITE 1000 High Sensitivity CRP",
        "IMMULITE 2000 High Sensitivity CRP"
    ],
    "Submitter Information": "Diagnostic Products Corporation",
    "510(k) Number": "K063057",
    "Predicate Device Reference 510(k) Number(s)": [
        "K003372",
        "K991385",
        "K033908"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NQD"
    ],
    "Summary Letter Date": "September 15, 2006",
    "Summary Letter Received Date": "October 5, 2006",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.5270"
    ],
    "Regulation Name(s)": [
        "C-reactive protein immunological test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "C-Reactive protein (CRP)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "IMMULITE Analyzer",
        "IMMULITE 1000 Analyzer",
        "IMMULITE 2000 Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent immunometric assay"
    ],
    "Methodologies": [
        "Immunometric assay"
    ],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for IMMULITE/IMMULITE 1000 and IMMULITE 2000 High Sensitivity CRP assays for quantitative measurement of CRP in serum or plasma",
    "Indications for Use Summary": "For in vitro diagnostic use with IMMULITE/IMMULITE 1000 or IMMULITE 2000 Analyzer for quantitative measurement of C-Reactive protein (CRP) in serum or plasma to aid detection/evaluation of infection, tissue injury, inflammatory disorders, and assessment of future cardiovascular disease risk including as independent marker for recurrent events in patients with stable coronary disease or acute coronary syndrome",
    "fda_folder": "Immunology"
}